Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sharps Technology, Inc. ( (STSS) ) has shared an announcement.
On January 15, 2026, Sharps Technology, Inc. entered into a 90-day lock-up agreement with its strategic advisor Sol Markets, under which the advisor agreed not to sell or otherwise dispose of its advisory warrants or underlying shares of STSS common stock, with the lock-up becoming effective January 16, 2026. Announced on January 16, 2026, shortly after the company’s approval of a share buyback program of up to $100 million, the voluntary lock-up is intended to signal Sol Markets’ confidence in Sharps’ strategic roadmap, align the advisor more closely with shareholders, and support market confidence as the company advances its Solana-focused digital asset treasury strategy and continues outreach to institutional investors.
More about Sharps Technology, Inc.
Sharps Technology, Inc. is an innovative medical device and pharmaceutical packaging company that develops patented smart-safety syringe products for the healthcare industry, emphasizing ultra-low waste designs with both passive and active safety features. The company has also adopted a digital asset treasury strategy centered on accumulating SOL, the native token of the Solana blockchain, using capital markets funding to pursue on-chain yield generation within the Solana ecosystem, supported by partnerships with platforms such as Coinbase, Crypto.com and Jupiter to advance a universal framework for digital identity and authentication.
Average Trading Volume: 399,596
Technical Sentiment Signal: Sell
Current Market Cap: $63.21M
Find detailed analytics on STSS stock on TipRanks’ Stock Analysis page.